GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | 8/14/2026 4:52:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $1,516,000 | EPS -$0.41 | ||
| Alaunos Therapeutics, Inc. (TCRT) | 5/15/2026 5:31:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $1,883,000 | EPS -$0.59 | ||
| Alaunos Therapeutics, Inc. (TCRT) | 4/30/2026 5:24:19 PM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Rev: $5,000 -50.0% | Assets $2,966,000 | EPS -$2.20 | |
| Alaunos Therapeutics, Inc. (TCRT) | 3/31/2026 4:44:10 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $5,000 -50.0% | Assets $2,966,000 | EPS -$2.20 | |
| Alaunos Therapeutics, Inc. (TCRT) | 11/14/2025 4:34:49 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $3,724,000 | EPS -$0.55 | ||
| Alaunos Therapeutics, Inc. (TCRT) | 8/14/2025 4:36:51 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $4,735,000 | EPS -$0.63 | ||
| Alaunos Therapeutics, Inc. (TCRT) | 5/21/2025 8:44:06 AM | View | Proxy | SEC | Y 2024 | ||||||
| Alaunos Therapeutics, Inc. (TCRT) | 5/15/2025 4:34:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $2,000 +100.0% | Assets $2,120,000 | EPS -$0.67 | |
| Alaunos Therapeutics, Inc. (TCRT) | 4/30/2025 5:05:10 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Rev: $10,000 +100.0% | Assets $2,755,000 | EPS -$2.92 | |
| Alaunos Therapeutics, Inc. (TCRT) | 3/31/2025 4:27:36 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $10,000 +100.0% | Assets $2,755,000 | EPS -$2.92 | |
| Alaunos Therapeutics, Inc. (TCRT) | 11/14/2024 9:42:33 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $3,550,000 | EPS -$0.70 | ||
| Alaunos Therapeutics, Inc. (TCRT) | 8/14/2024 5:06:23 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $4,000 0.0% | Assets $4,678,000 | EPS -$0.71 | |
| Alaunos Therapeutics, Inc. (TCRT) | 5/15/2024 9:05:58 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $1,000 | Assets $6,037,000 | EPS -$0.11 | |
| Alaunos Therapeutics, Inc. (TCRT) | 4/26/2024 5:01:57 PM | View | Proxy | SEC | Y 2023 | ||||||
| Alaunos Therapeutics, Inc. (TCRT) | 4/1/2024 7:48:32 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $5,000 -99.8% | Assets $8,263,000 | EPS -$21.97 | |
| Alaunos Therapeutics, Inc. (TCRT) | 11/14/2023 11:31:29 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $0 | Assets $19,440,000 | EPS -$5.30 | Export Earnings Model | |
| Alaunos Therapeutics, Inc. (TCRT) | 11/14/2023 7:45:55 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $19,440,000 | EPS -$5.30 | ||
| Alaunos Therapeutics, Inc. (TCRT) | 8/14/2023 4:46:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $4,000 | Assets $27,927,000 | EPS -$5.49 | |
| Alaunos Therapeutics, Inc. (TCRT) | 8/14/2023 4:22:54 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $4,000 | Assets $27,927,000 | EPS -$5.49 | Export Earnings Model | |
| Alaunos Therapeutics, Inc. (TCRT) | 5/10/2023 7:43:27 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $48,638,000 | EPS -$0.63 | ||
| Alaunos Therapeutics, Inc. (TCRT) | 5/10/2023 7:10:33 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $0 | Assets $48,638,000 | EPS -$0.63 | Export Earnings Model | |
| Alaunos Therapeutics, Inc. (TCRT) | 4/25/2023 5:03:38 PM | View | Proxy | SEC | Y 2022 | ||||||
| Alaunos Therapeutics, Inc. (TCRT) | 3/7/2023 7:40:01 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $2,922,000 +634.2% | Assets $64,937,000 | EPS -$2.61 | |
| Alaunos Therapeutics, Inc. (TCRT) | 3/7/2023 7:08:25 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $11,000 | Assets $64,937,000 | EPS -$2.48 | Export Earnings Model | |
| Alaunos Therapeutics, Inc. (TCRT) | 11/14/2022 7:47:48 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $2,911,000 +631.4% | Assets $67,344,000 | EPS -$0.04 | |
| Alaunos Therapeutics, Inc. (TCRT) | 11/14/2022 7:07:09 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $2,911,000 +631.4% | Assets $67,344,000 | EPS -$0.04 | Export Earnings Model | |
| Alaunos Therapeutics, Inc. (TCRT) | 8/15/2022 7:49:32 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $73,931,000 | EPS -$0.05 | ||
| Alaunos Therapeutics, Inc. (TCRT) | 8/15/2022 7:12:23 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $0 | Assets $73,931,000 | EPS -$0.05 | Export Earnings Model | |
| Alaunos Therapeutics, Inc. (TCRT) | 5/16/2022 7:47:02 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $84,991,000 | EPS -$0.05 | ||
| Alaunos Therapeutics, Inc. (TCRT) | 5/16/2022 7:32:14 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $84,991,000 | EPS -$0.05 | Export Earnings Model | ||
| Alaunos Therapeutics, Inc. (TCRT) | 4/27/2022 4:34:55 PM | View | Proxy | SEC | Y 2021 | ||||||
| Alaunos Therapeutics, Inc. (TCRT) | 3/30/2022 8:09:30 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $398,000 | Assets $94,865,000 | EPS -$0.37 | |
| Alaunos Therapeutics, Inc. (TCRT) | 3/30/2022 7:56:06 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $0 | Assets $94,865,000 | EPS -$0.06 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/8/2021 4:21:02 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $398,000 +5,585.7% | Assets $113,762,000 | EPS -$0.11 | |
| Ziopharm Oncology Inc (TCRT) | 11/8/2021 4:13:37 PM | View | Financials | Earnings | WIRE | 3Q 2021 | Rev $398,000 +5,585.7% | Assets $113,762,000 | EPS -$0.11 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/13/2021 5:03:19 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $106,765,000 | EPS -$0.11 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/9/2021 5:04:49 PM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $106,765,000 | EPS -$0.11 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/6/2021 4:42:53 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $128,472,000 | EPS -$0.10 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/6/2021 4:27:06 PM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $128,472,000 | EPS -$0.10 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/7/2021 8:47:04 AM | View | Proxy | SEC | Y 2020 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/1/2021 4:14:38 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $146,345,000 | EPS -$0.38 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 2/25/2021 4:12:17 PM | View | Financials | Earnings | SEC | Y 2020 | Rev ($412,000) | Assets $146,345,000 | EPS -$0.11 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/5/2020 4:18:09 PM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $7,000 | Assets $165,894,000 | EPS -$0.10 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/5/2020 4:13:31 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $7,000 | Assets $165,894,000 | EPS -$0.10 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/2/2020 8:34:50 AM | View | Proxy | SEC | Y 2019 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 10/30/2020 4:47:09 PM | View | Proxy | SEC | Y 2019 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/6/2020 4:23:33 PM | View | Financials | Earnings | SEC | 2Q 2020 | Assets $181,679,000 | EPS -$0.09 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/6/2020 4:20:30 PM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $181,679,000 | EPS -$0.09 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/18/2020 4:39:06 PM | View | Proxy | SEC | Y 2019 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/7/2020 4:14:11 PM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $198,279,000 | EPS -$0.09 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/2/2020 4:28:22 PM | View | Financials | Earnings | SEC | Y 2019 | Assets $109,114,000 | EPS -$0.09 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/2/2020 4:17:19 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $109,114,000 | EPS -$0.70 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/7/2019 4:40:29 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $117,949,000 | EPS -$0.43 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/7/2019 4:36:43 PM | View | Financials | Earnings | SEC | 3Q 2019 | Assets $117,949,000 | EPS -$0.43 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/8/2019 8:01:57 AM | View | Financials | Earnings | SEC | 2Q 2019 | Assets $73,173,000 | EPS -$0.09 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/8/2019 7:55:17 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $73,173,000 | EPS -$0.09 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/8/2019 4:21:37 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $83,503,000 | EPS -$0.08 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/8/2019 4:14:02 PM | View | Financials | Earnings | SEC | 1Q 2019 | Assets $83,503,000 | EPS -$0.08 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/29/2019 4:50:12 PM | View | Proxy | SEC | Y 2018 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/5/2019 4:26:22 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $146,000 -97.7% | Assets $95,051,000 | EPS $0.96 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/5/2019 4:13:37 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $0 | Assets $95,051,000 | EPS $1.29 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/9/2018 8:13:08 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $66,801,000 | EPS -$0.13 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/8/2018 4:54:06 PM | View | Proxy | SEC | Y 2017 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/8/2018 4:15:46 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $76,383,000 | EPS -$0.12 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/8/2018 4:10:18 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $0 | Assets $76,383,000 | EPS -$0.12 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/10/2018 5:05:54 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $146,000 -90.9% | Assets $87,461,000 | EPS -$0.15 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/10/2018 4:14:35 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $146,000 -90.9% | Assets $87,461,000 | EPS -$0.15 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/1/2018 5:22:30 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $6,389,000 -6.9% | Assets $105,606,000 | EPS -$0.53 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/1/2018 4:24:24 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $1,597,000 0.0% | Assets $105,606,000 | EPS -$0.12 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/6/2017 4:15:29 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $1,598,000 0.0% | Assets $116,559,000 | EPS -$0.13 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/6/2017 4:10:56 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $1,598,000 0.0% | Assets $116,559,000 | EPS -$0.13 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 7/31/2017 4:17:40 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $1,597,000 -5.9% | Assets $126,813,000 | EPS -$0.13 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 7/31/2017 4:11:04 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $1,597,000 -5.9% | Assets $126,813,000 | EPS -$0.13 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/1/2017 4:13:28 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $1,597,000 -18.9% | Assets $94,494,000 | EPS -$0.15 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/1/2017 4:12:22 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $1,597,000 -18.9% | Assets $94,494,000 | EPS -$0.15 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/28/2017 4:31:11 PM | View | Proxy | SEC | Y 2016 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 2/16/2017 4:10:32 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $1,597,000 -16.8% | Assets $106,348,000 | EPS -$0.11 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 2/16/2017 4:03:12 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $6,861,000 +58.4% | Assets $106,348,000 | EPS -$1.32 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/9/2016 4:15:56 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $1,598,000 -14.5% | Assets $117,122,000 | EPS -$0.11 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/9/2016 4:02:08 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $1,598,000 -14.5% | Assets $117,122,000 | EPS -$0.11 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/9/2016 4:13:02 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $1,697,000 +523.9% | Assets $128,012,000 | EPS -$1.01 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/9/2016 4:02:08 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $1,697,000 +523.9% | Assets $128,012,000 | EPS -$1.01 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/10/2016 4:15:39 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $1,969,000 +623.9% | Assets $141,682,000 | EPS -$0.09 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/10/2016 4:01:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $1,969,000 +623.9% | Assets $141,682,000 | EPS -$0.09 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/28/2016 4:40:41 PM | View | Proxy | SEC | Y 2015 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 2/24/2016 5:04:33 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $1,919,000 +464.4% | Assets $153,724,000 | EPS -$0.07 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 2/24/2016 4:42:15 PM | Small | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $4,332,000 +215.5% | Assets $153,724,000 | EPS -$0.96 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/2/2015 4:15:54 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $1,869,000 +195.3% | Assets $173,361,000 | EPS -$0.14 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/2/2015 4:02:34 PM | Small | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $1,869,000 +195.3% | Assets $173,361,000 | EPS -$0.14 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/10/2015 4:31:34 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $272,000 +36.0% | Assets $124,038,000 | EPS -$0.11 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/10/2015 4:01:08 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $272,000 +36.0% | Assets $124,038,000 | EPS -$0.11 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/7/2015 4:54:33 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $272,000 +36.0% | Assets $131,648,000 | EPS -$0.69 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/7/2015 4:23:23 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $272,000 +36.0% | Assets $131,648,000 | EPS -$0.69 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/30/2015 4:31:35 PM | View | Proxy | SEC | Y 2014 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 2/26/2015 5:19:33 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $340,000 +70.0% | Assets $45,237,000 | EPS -$0.09 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 2/26/2015 5:03:23 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $1,373,000 +71.6% | Assets $45,237,000 | EPS -$0.31 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 2/2/2015 4:56:34 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $340,000 +70.0% | Assets $45,237,000 | EPS -$0.09 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 10/30/2014 4:10:35 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $633,000 +216.5% | Assets $49,109,000 | EPS -$0.06 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 10/30/2014 4:01:25 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $633,000 +216.5% | Assets $49,109,000 | EPS -$0.06 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/7/2014 4:20:37 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $200,000 0.0% | Assets $55,348,000 | EPS -$0.06 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/7/2014 4:01:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $200,000 0.0% | Assets $55,348,000 | EPS -$0.06 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/8/2014 4:10:33 PM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $200,000 0.0% | Assets $63,325,000 | EPS -$0.10 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/8/2014 4:01:23 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $200,000 0.0% | Assets $63,325,000 | EPS -$0.10 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/30/2014 4:17:14 PM | View | Proxy | SEC | Y 2013 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/3/2014 4:50:33 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $200,000 0.0% | Assets $71,754,000 | EPS -$0.09 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/3/2014 4:29:31 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $800,000 0.0% | Assets $71,754,000 | EPS -$0.66 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 10/22/2013 4:04:33 PM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $200,000 0.0% | Assets $29,478,000 | EPS -$0.20 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 10/22/2013 4:02:13 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $200,000 0.0% | Assets $29,478,000 | EPS -$0.20 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/8/2013 4:01:48 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $200,000 0.0% | Assets $45,603,000 | EPS -$0.22 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/7/2013 4:01:27 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $200,000 0.0% | Assets $63,346,000 | EPS -$0.15 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/29/2013 6:15:27 AM | View | Proxy | SEC | Y 2012 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/4/2013 9:11:39 PM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $200,000 0.0% | Assets $63,346,000 | EPS -$0.15 | Export Earnings Model | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/18/2013 4:01:06 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $800,000 +19.9% | Assets $83,404,000 | EPS -$1.22 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/8/2012 4:12:11 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $200,000 0.0% | Assets $105,640,000 | EPS -$0.23 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/28/2012 4:07:43 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $200,000 0.0% | Assets $122,380,000 | EPS -$0.30 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/3/2012 4:06:59 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $200,000 +198.5% | Assets $140,873,000 | EPS -$0.32 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/30/2012 4:30:47 PM | View | Proxy | SEC | Y 2011 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 2/29/2012 4:08:16 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $667,000 | Assets $108,108,000 | EPS -$0.97 | |
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/1/2011 6:02:50 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2010 ending: 9/30/2010 | Assets $67,450,000 | EPS -$0.26 | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/1/2011 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Assets $67,450,000 | EPS -$0.26 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/5/2011 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Assets $67,450,000 | EPS -$0.26 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/2/2011 3:00:47 PM | View | Proxy | SEC | Y 2010 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/1/2011 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Assets $67,450,000 | EPS -$0.26 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 2/3/2011 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Assets $67,450,000 | EPS -$0.26 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/4/2010 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Assets $67,450,000 | EPS -$0.26 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/14/2010 10:16:19 AM | View | Proxy | SEC | Y 2009 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/30/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Export Earnings Model | ||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/18/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Assets $49,736,000 | EPS $0.07 | Export Earnings Model | ||
| ZIOPHARM ONCOLOGY INC (TCRT) | 11/12/2009 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2009 | EPS -$0.13 | Export Earnings Model | |||
| ZIOPHARM ONCOLOGY INC (TCRT) | 8/14/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Export Earnings Model | ||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 5/15/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 4/20/2009 4:03:13 PM | View | Proxy | SEC | Y 2008 | ||||||
| ZIOPHARM ONCOLOGY INC (TCRT) | 3/24/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |